Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 1

Results: 40
    1

    Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

    Published in:
    2025
    By:
    • De Jaeghere, Emiel A.;
    • Tuyaerts, Sandra;
    • Van Nufel, An M. T.;
    • Belmans, Ann;
    • Bogaerts, Kris;
    • Baiden-Amissah, Regina;
    • Lippens, Lien;
    • Vuylsteke, Peter;
    • Henry, Stéphanie;
    • Trinh, Xuan Bich;
    • van Dam, Peter A.;
    • Aspeslagh, Sandrine;
    • De Caluwé, Alex;
    • Naert, Eline;
    • Lambrechts, Diether;
    • Hendrix, An;
    • De Wever, Olivier;
    • Van de Vijver, Koen K.;
    • Amant, Frédéric;
    • Vandecasteele, Katrien
    Publication type:
    Correction Notice
    2
    3

    Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.

    Published in:
    2025
    By:
    • Fujimoto, Airi;
    • Koutake, Yoshimichi;
    • Hisamatsu, Daisuke;
    • Ookubo, Noriko;
    • Yabuuchi, Yurika;
    • Kamimura, Go;
    • Kai, Tatsuo;
    • Kozono, Aki;
    • Ootsu, Takahiro;
    • Suzuki, Hiroto;
    • Matsuo, Keisuke;
    • Kuwahara, Kimiko;
    • Oiwane, Yoshita;
    • Nagata, Yuko;
    • Tanimoto, Kenya;
    • Sato, Eri;
    • Suenaga, Mei;
    • Uehara, Tomohiro;
    • Ikari, Akira;
    • Endo, Satoshi
    Publication type:
    Correction Notice
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03871-7
    By:
    • Pichler, Renate;
    • Fritz, Josef;
    • Maier, Sarah;
    • Hassler, Melanie R.;
    • Krauter, Johanna;
    • D`Andrea, David;
    • Laukhtina, Ekaterina;
    • Gust, Kilian;
    • Mori, Keiichiro;
    • Tully, Karl H.;
    • Niedersuess-Beke, Dora;
    • Korber, Lea;
    • Spiegelberg, Jasmin Alija;
    • Bauernhofer, Thomas;
    • Subiela, José D.;
    • Mayr, Roman;
    • Kronbichler, Andreas;
    • Moschini, Marco;
    • Teoh, Jeremy;
    • Pradere, Benjamin
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03862-8
    By:
    • Morimoto, Soyoko;
    • Tanaka, Yukie;
    • Nakata, Jun;
    • Fujiki, Fumihiro;
    • Hasegawa, Kana;
    • Nakajima, Hiroko;
    • Nishida, Sumiyuki;
    • Tsuboi, Akihiro;
    • Hosen, Naoki;
    • Kagawa, Naoki;
    • Maruno, Motohiko;
    • Myoui, Akira;
    • Enomoto, Takayuki;
    • Izumoto, Shuichi;
    • Sekimoto, Mitsugu;
    • Hashimoto, Naoya;
    • Yoshimine, Toshiki;
    • Kumanogoh, Atsushi;
    • Oji, Yusuke;
    • Oka, Yoshihiro
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.

    Published in:
    Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03860-w
    By:
    • Galvagno, Federica;
    • Leuci, Valeria;
    • Massa, Annamaria;
    • Donini, Chiara;
    • Rotolo, Ramona;
    • Capellero, Sonia;
    • Proment, Alessia;
    • Vitali, Letizia;
    • Lombardi, Andrea Maria;
    • Tuninetti, Valentina;
    • D'Ambrosio, Lorenzo;
    • Merlini, Alessandra;
    • Vigna, Elisa;
    • Valabrega, Giorgio;
    • Primo, Luca;
    • Puliafito, Alberto;
    • Sangiolo, Dario
    Publication type:
    Article
    35
    36
    37
    38
    39
    40